Orin Hirschman
Directeur Général chez AIGH Capital Management LLC
Fortune : 374 448 $ au 31/05/2024
Provenance du réseau au premier degré de Orin Hirschman
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Ohr Pharmaceutical, Inc.
 Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY.
11
| Extinct | Pharmaceuticals: Major | 11 |
Touro College
6
| College/University | Other Consumer Services | 6 |
D.H. Blair & Co., Inc.
2
| Private Company | 2 | |
AIGH Capital Management LLC
 AIGH Capital Management LLC Investment ManagersFinance AIGH Capital Management LLC (AIGH) is a SEC-registered investment advisor headquartered in Baltimore, Maryland. The firm was founded in 2011 and is owned by AIGH Investment Partners LLC. AIGH provides discretionary investment advisory services to private investment funds and sub advises private funds.
2
| Subsidiary | Investment Managers | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Orin Hirschman via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
DepYmed, Inc.
 DepYmed, Inc. BiotechnologyHealth Technology DepYmed , Inc. is a cancer and rare disease therapeutic development company. The company is headquartered in Farmingdale, NY. | Biotechnology | Director/Board Member Founder Founder | |
| The Retina Society | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | ||
SKS Ocular LLC
 SKS Ocular LLC BiotechnologyHealth Technology SKS Ocular, LLC is a private ophthalmology company incubator that uses state-of-the-art research and development technologies to discover and advance novel therapeutics through preclinical or clinical proof of concept. | Biotechnology | Chief Executive Officer Founder Founder | |
| NANOVIBRONIX, INC. | Medical Specialties | Chairman Director/Board Member | |
| Macula Society | Corporate Officer/Principal Corporate Officer/Principal | ||
| American Society of Retinal Specialists | Corporate Officer/Principal Corporate Officer/Principal | ||
| Hofstra University | College/University | Undergraduate Degree Undergraduate Degree | |
American Ophthalmological Society
 American Ophthalmological Society Miscellaneous Commercial ServicesCommercial Services The American Ophthalmological Society is an organization that aims to promote excellence in patient care, education, and research in the field of ophthalmology. The society is based in San Francisco, CA, and was founded in 1864 by Edward Delafield, Daniel Bennett St. John Roosa, and Henry Noyes. The private company addresses essential issues in medicine and advance the art and science of ophthalmology. The society holds annual meetings every third week of May each year, and they offer travel grants to non-members who wish to attend. Membership nominations are accepted until April 30th each year. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Orphion Therapeutics, Inc.
 Orphion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orphion Therapeutics, Inc. develops novel gene therapies for the treatment of genetic disorders. The private company is based in Great Neck, NY. The company was founded by Samuel I. Backenroth. The CEO is Jason Scott Slakter. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| FORAFRIC GLOBAL PLC | Agricultural Commodities/Milling | Director/Board Member Director/Board Member | |
Citibank NA (New York)
 Citibank NA (New York) Major BanksFinance Citibank NA engages in the provision of banking services. It offers retail and commercial banking; credit cards; banking, capital markets, and advisory; markets and securities services; private banking; and treasury and trade solutions. The company was founded on June 16, 1812 and is headquartered in New York, NY. | Major Banks | Corporate Officer/Principal | |
| Sitara Pharmaceutical Consulting LLC | Founder | ||
| University of Mumbai | College/University | Graduate Degree | |
Mystic Pharmaceuticals, Inc.
 Mystic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mystic Pharmaceuticals, Inc. manufactures and wholesales pharmaceutical and biological products. The private company was founded in 2003 and is based in Austin, TX. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Queens College | College/University | Director/Board Member | |
Advanced Viral Research Corp.
 Advanced Viral Research Corp. Pharmaceuticals: MajorHealth Technology Advanced Viral Research Corp. is a biopharmaceutical company, engages in the research, development, and commercialization of small molecule therapeutics that address medical needs for various degenerative conditions. Its products include AVR118, a cytoprotective drug composed of a complex mixture of protein and ribonucleic acid components; AVR123, a form of AVR118 specially designed for dermatology applications, which is in Phase II clinical trials; AVR147, an inhibitor of a cancer target known as a proteasome; AVR168 that is a natural product, which inhibits a member of a family of motor proteins that are responsible for the assembly and function of microtubules during cell division. The company was founded in July 1985 and is headquartered in Yonkers, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| JMJ Management Co., Inc. | Chief Executive Officer | ||
| Philadelphia College of Pharmacy | College/University | Doctorate Degree | |
| NANOVIRICIDES, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| Barington Offshore Advisors II LLC | Chief Executive Officer | ||
Prodos Capital LLC
 Prodos Capital LLC Investment ManagersFinance Prodos Capital LLC (Prodos) is a private equity firm founded in 2003. The firm is headquartered in Nashville, Tennessee. | Investment Managers | Consultant / Advisor | |
Barington Companies Investors LLC
 Barington Companies Investors LLC Investment ManagersFinance Barington Companies Investors LLC (BCI) is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 1999 and is majority-owned by Barington Capital Group LP, which is owned by LNA Capital Corp. BCI is the general partner of, and provides discretionary investment advisory services to, Barington Companies Equity Partners LP, a Delaware limited partnership. | Investment Managers | Chief Executive Officer | |
| GRIFFON CORPORATION | Building Products | Director/Board Member | |
| PEP BOYS - MANNY MOE & JACK | Wholesale Distributors | Chairman | |
Barington Capital Group LP
 Barington Capital Group LP Investment ManagersFinance Barington Capital Group LP provides investment advisory services. It invests in the public equity markets of the United States. The firm manages limited partnerships for its clients. The company was founded in 1991 by James Anthony Mitarotonda and is headquartered in New York, NY. | Investment Managers | Chief Executive Officer | |
EOM Pharmaceuticals, Inc.
 EOM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of EOM Pharmaceuticals Holdings, Inc., EOM Pharmaceuticals, Inc. is a privately held, clinical-stage company focused on developing novel drugs to improve the quality of life for patients with debilitating and sometimes deadly diseases. The company is based in Montvale, NJ. The company's mission is to pursue innovative approaches with small molecule therapeutics to address urgent and unmet medical needs. EOM's pipeline includes the development of the first-and-only dual-acting, broad-spectrum immunomodulator EOM613, which has the potential to treat systemic illnesses caused by intense inflammatory immune reactions, including COVID-19, influenza, and cancer cachexia. Additionally, EOM is working on an advanced formulation of EOM147, the first potential topically administered eye drop for treating retinal diseases. The company was founded by Shalom Z. Hirschman and Eli Goldberger, and Irach B. Taraporewala has been the CEO since 2020. EOM Pharmaceuticals was acquired by ImmunoCellular Therapeutics Ltd. on December 02, 2021. | Pharmaceuticals: Major | Chief Executive Officer | |
| EOM PHARMACEUTICALS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Utah | College/University | Undergraduate Degree | |
Barington Companies Management LLC
 Barington Companies Management LLC Miscellaneous Commercial ServicesCommercial Services Barington Companies Management LLC provides business consulting services. The company is based in New York, NY. The CEO of the company is James Anthony Mitarotonda. | Miscellaneous Commercial Services | Chief Executive Officer | |
A. Schulman, Inc. Ltd.
 A. Schulman, Inc. Ltd. Miscellaneous ManufacturingProducer Manufacturing Part of LyondellBasell Industries NV, A. Schulman, Inc. Ltd. is a British company that manufactures and wholesales plastic products. The company is based in Crumlin, UK and was founded in 1952. | Miscellaneous Manufacturing | Director/Board Member | |
| The Friends of Green Chimneys | Director/Board Member | ||
| Barington Cos Equity Partners LP | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
| DESTINATION XL GROUP, INC. | Apparel/Footwear Retail | Director/Board Member | |
Ameron International Corp.
 Ameron International Corp. Construction MaterialsNon-Energy Minerals Ameron International Corp. is a manufactures engineered products and materials for the chemical, industrial, energy, transportation and infrastructure markets. It produces water transmission lines: fiberglass-composite pipe for transporting oil, chemicals and corrosive fluids and specialized materials and products used in infrastructure projects, such as poles, construction materials and wind towers. The company was founded in 1907 and is headquartered in Houston, TX. | Construction Materials | Director/Board Member | |
Gerber Scientific LLC
 Gerber Scientific LLC Industrial MachineryProducer Manufacturing Gerber Scientific LLC produces automated manufacturing systems for the sign making, specialty graphics and packaging, apparel and flexible materials and ophthalmic lens processing industries. It also serves fashion and apparel, transportation, aerospace and furniture industries. The company was founded by H. Joseph Gerber in 1968 and is headquartered in Tolland, CT. | Industrial Machinery | Director/Board Member | |
| A SCHULMAN INC | Chemicals: Specialty | Director/Board Member | |
| COSTAR TECHNOLOGIES, INC. | Telecommunications Equipment | Chief Executive Officer | |
| LNA Capital Corp. | Director/Board Member | ||
| BARINGTON/HILCO ACQUISITION CORP | Financial Conglomerates | Chief Executive Officer | |
| EBIX, INC. | Packaged Software | Director/Board Member | |
| RAMBUS INC. | Semiconductors | Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| OMNOVA SOLUTIONS INC. | Chemicals: Major Diversified | Director/Board Member | |
| THE EASTERN COMPANY | Tools & Hardware | Chairman | |
| Sielox LLC | Director/Board Member | ||
| Mt. Olympus Resources, Inc. | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 48 |
| Inde | 2 |
| Royaume-Uni | 2 |
Sectorielle
| Health Technology | 11 |
| Consumer Services | 7 |
| Finance | 7 |
| Process Industries | 4 |
| Producer Manufacturing | 4 |
Opérationnelle
| Director/Board Member | 84 |
| Corporate Officer/Principal | 45 |
| President | 34 |
| Chairman | 32 |
| Chief Executive Officer | 30 |
Relations les plus connectées
| Insiders | |
|---|---|
| James Mitarotonda | 35 |
| Lindsay Rosenwald | 23 |
| Ira Greenstein | 23 |
| Steven Yehuda Moskowitz | 15 |
| June Almenoff | 14 |
| Asher Zwebner | 13 |
| Thomas M. Riedhammer | 13 |
| Jason Scott Slakter | 11 |
| Irach Taraporewala | 11 |
| Andrew Limpert | 10 |
| Michael Ferguson | 10 |
| Peter K. Kaiser | 9 |
| Randy Scott Zelin | 8 |
| Samuel Backenroth | 8 |
| Mark R. Basile | 7 |
- Bourse
- Insiders
- Orin Hirschman
- Connexions Sociétés
